Nov. 1, 2018
A study recently published in Scientific Reports discovered that 65% of Lyme disease patients irrespective of their disease stage respond to several microbes. As a consequence, the authors have demonstrated that microbial infections in individuals suffering from Lyme disease do not follow the “one microbe, one disease” status-quo. Moreover, the probability that Lyme disease patients would respond to multiple microbes associated with the tick-borne disease is an astounding 85 %.
Researchers have observed a remarkable 65% Lyme disease (LD) patients at different disease stages, respond to various microbes signifying that microbial infections in LD patients do not follow the “one microbe, one disease” Germ Theory. Furthermore, the authors have indicated a novel Borrelia biomarker, “Borrelia persistent form,” that can enhance the sensitivity of any existing LD diagnostic tests. Using the Centers for Disease Control and Prevention (CDC) recommended two-tier method, Garg et al., show that 72% of individuals (i.e., 3 / 4 individuals) classified “negative” by the CDC two-tier LD test, were positive for ‘Borrelia persistent form’ and other microbes such as Babesia, Bartonella, and Ehrlichia. Co-infections transmitted by the ticks to humans are common and documented in multiple countries like Australia, Germany, the Netherlands, Sweden, the UK, and the US to mention the least. However, the research by Garg et al. argues that prolonged exposure to tick transmitted microbes weakens the human immune system increasing the host’s vulnerability to other common microbes’ labelled “non-tick-borne opportunistic microbes,” such as ….